Cannabis use in older adults
An article in The Gerontologist discusses the implications of the rising use of cannabis in older Americans. Read more
Web Exclusives
ADA releases position statement on diabetic neuropathy
The American Diabetes Association (ADA) has released a position statement on diabetic neuropathy that outlines recommendations for preventing and managing the condition. Read more
Patient on the precipice
Richard Hamilton, age 67, is admitted to the telemetry unit from the emergency department (ED) with new-onset chest pain. In the ED, his troponin test…
FDA approves first drug for treating spinal muscular dystrophy
On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular…
Indoor smoking bans reduce children’s asthma ED visits
Emergency departments (EDs) in communities with indoor smoking bans report a 17% decrease in the number of children needing care for asthma attack, according…
Breaking down diversability barriers to improve patient well-being
Many of us make assumptions based on a person’s appearance, behavior, our personal experiences, and what we believe that person might be thinking. But…
FDA expands indication for continuous glucose monitoring system
On Dec. 20, the Food and Drug Administration (FDA) expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for…
FDA approves new treatment for advanced ovarian cancer
On Dec. 19, the Food and Drug Administration (FDA) approved Rubraca (rucaparib) to treat women with advanced ovarian cancer who have been treated with…
Regular use of aspirin may reduce pancreatic cancer risk
Regular use of aspirin was associated with a lower risk of pancreatic cancer in people living in Shanghai, China. Read more
FDA issues warning about anesthesia/sedation use in young children and pregnant women
On Dec. 14, the Food and Drug Administration (FDA) released a safety communication warning that repeated or lengthy use of general anesthetic and sedation…
FDA approves new treatment for eczema
On Dec. 14, the Food and Drug Administration (FDA) approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema in patients 2 years of…
Cannabis use in older adults
An article in The Gerontologist discusses the implications of the rising use of cannabis in older Americans. Read more
ADA releases position statement on diabetic neuropathy
The American Diabetes Association (ADA) has released a position statement on diabetic neuropathy that outlines recommendations for preventing and managing the condition.…
Patient on the precipice
Richard Hamilton, age 67, is admitted to the telemetry unit from the emergency department (ED) with new-onset chest pain. In the ED, his…
FDA approves first drug for treating spinal muscular dystrophy
On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with…
Indoor smoking bans reduce children’s asthma ED visits
Emergency departments (EDs) in communities with indoor smoking bans report a 17% decrease in the number of children needing care for asthma…
Breaking down diversability barriers to improve patient well-being
Many of us make assumptions based on a person’s appearance, behavior, our personal experiences, and what we believe that person might be…
FDA expands indication for continuous glucose monitoring system
On Dec. 20, the Food and Drug Administration (FDA) expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to…
FDA approves new treatment for advanced ovarian cancer
On Dec. 19, the Food and Drug Administration (FDA) approved Rubraca (rucaparib) to treat women with advanced ovarian cancer who have been…
Regular use of aspirin may reduce pancreatic cancer risk
Regular use of aspirin was associated with a lower risk of pancreatic cancer in people living in Shanghai, China. Read more
FDA issues warning about anesthesia/sedation use in young children and pregnant women
On Dec. 14, the Food and Drug Administration (FDA) released a safety communication warning that repeated or lengthy use of general anesthetic…
FDA approves new treatment for eczema
On Dec. 14, the Food and Drug Administration (FDA) approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema in patients 2…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.